Cargando…
Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice
Starting Parkinson’s disease (PD) patients on subcutaneous apomorphine (APO) infusion is generally undertaken on a hospital day-case basis. During the COVID-19 pandemic, day-case facilities were unavailable. To avoid delays in treatment, a new procedure was developed for initiation of APO therapy in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645639/ https://www.ncbi.nlm.nih.gov/pubmed/37870634 http://dx.doi.org/10.1007/s00702-023-02710-w |